USD
$0.00
(0.00%
)At Close (As of Nov 14, 2025)
$12.57M
Market Cap
-
P/E Ratio
-5.04
EPS
$14.97
52 Week High
$2.73
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $9.5M |
| Total Revenue | $18M |
| Cost Of Revenue | $8.4M |
| Costof Goods And Services Sold | $8.4M |
| Operating Income | -$10M |
| Selling General And Administrative | $8.8M |
| Research And Development | $3.9M |
| Operating Expenses | $20M |
| Investment Income Net | - |
| Net Interest Income | -$269K |
| Interest Income | - |
| Interest Expense | $269K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $1.6M |
| Income Before Tax | -$11M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$11M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$11M |
| Ebitda | -$9.5M |
| Net Income | -$11M |
| Field | Value (USD) |
|---|---|
| Total Assets | $27M |
| Total Current Assets | $19M |
| Cash And Cash Equivalents At Carrying Value | $6.5M |
| Cash And Short Term Investments | $6.5M |
| Inventory | $4.6M |
| Current Net Receivables | $7.2M |
| Total Non Current Assets | $7.8M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $4.6M |
| Intangible Assets Excluding Goodwill | $4.6M |
| Goodwill | $431K |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $541K |
| Other Non Current Assets | - |
| Total Liabilities | $14M |
| Total Current Liabilities | $7.5M |
| Current Accounts Payable | $1.6M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $1.7M |
| Total Non Current Liabilities | $6.4M |
| Capital Lease Obligations | $879K |
| Long Term Debt | $3.9M |
| Current Long Term Debt | $1.3M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $6M |
| Other Current Liabilities | $2.4M |
| Other Non Current Liabilities | $181K |
| Total Shareholder Equity | $13M |
| Treasury Stock | - |
| Retained Earnings | -$250M |
| Common Stock | $22K |
| Common Stock Shares Outstanding | $20M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$9.8M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $1.6M |
| Capital Expenditures | $37K |
| Change In Receivables | - |
| Change In Inventory | $257K |
| Profit Loss | - |
| Cashflow From Investment | -$37K |
| Cashflow From Financing | $7.8M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$11M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $9.5M |
| Total Revenue | $18M |
| Cost Of Revenue | $8.4M |
| Costof Goods And Services Sold | $8.4M |
| Operating Income | -$10M |
| Selling General And Administrative | $8.8M |
| Research And Development | $3.9M |
| Operating Expenses | $20M |
| Investment Income Net | - |
| Net Interest Income | -$269K |
| Interest Income | - |
| Interest Expense | $269K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $1.6M |
| Income Before Tax | -$11M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$11M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$11M |
| Ebitda | -$9.5M |
| Net Income | -$11M |
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
Ekso Bionics Holdings, Inc. is a pioneering leader in the design and development of advanced exoskeleton technology aimed at enhancing mobility and rehabilitation for individuals with physical impairments. Based in Richmond, California, Ekso Bionics offers a range of innovative exoskeleton products and rental options, serving a diverse clientele that includes healthcare providers and industrial sectors. The company’s focus on improving patient outcomes and maximizing human performance positions it favorably within the emerging wearable robotics market, representing a compelling investment opportunity for institutional investors seeking to capitalize on advancements in healthcare technology.